key: cord-0909165-0vsywmd5
authors: Geraci, Travis C.; Narula, Navneet; Smith, Deane E.; Moreira, Andre L.; Kon, Zachary N.; Chang, Stephanie H.
title: Lobectomy for Hemorrhagic Lobar Infarction in a Patient with COVID-19
date: 2020-09-25
journal: Ann Thorac Surg
DOI: 10.1016/j.athoracsur.2020.08.003
sha: c3ab63b1db44d7197b1a06d3f54efc315aa01892
doc_id: 909165
cord_uid: 0vsywmd5

Patients with severe coronavirus disease 2019 (COVID-19) from infection with acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mount a profound inflammatory response and are predisposed to thrombotic complications [1]. Pulmonary vein thrombosis is a rare disease process resulting in pulmonary congestion, infarction, and potential mortality. This report describes a patient with COVID-19 requiring veno-venous extracorporeal membrane oxygenation (VV-ECMO) for hypoxic respiratory failure, who developed hemorrhagic infarction of the right lower lobe. During emergency exploration, the patient was found to have a right inferior vein thrombosis and marked lobar hemorrhage mandating lobectomy.

While the majority of patients with coronavirus disease 2019 (COVID-19) develop moderate symptoms, patients hospitalized with severe disease may require mechanical ventilation for hypoxic respiratory failure [2] . Veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been employed as rescue therapy in select patients failing ventilator support [3] . Patients with severe COVID-19 also mount a profound inflammatory response and are predisposed to thrombotic complications [1] .

This report describes a patient with severe COVID-19, who developed hemorrhagic infarction of the right lower lobe while on VV-ECMO support. During emergency exploration, the patient was found to have a right inferior vein thrombosis and marked lobar hemorrhage mandating lobectomy. To our knowledge, this is the first report of a patient requiring lobectomy for COVID-19 disease.

A 33-year-old male with no past medical history presented to the emergency department with a

week-long history of fever, progressive dyspnea, and non-productive cough despite antibiotic therapy prescribed four days prior for a suspected pneumonia. The patient was found to be COVID-19 positive and hypoxic with diffuse bilateral pulmonary infiltrates suggestive of acute respiratory distress syndrome.

The patient was admitted to the intensive care unit (ICU) and intubated within 8 hours for progressive hypoxia and hypercarbia. Over the following 48 hours, the patient was sedated and paralyzed for ventilator dyssynchrony and persistent hypoxia despite maximal ventilator settings, and required vasopressors for hemodynamic support. Given the patient's young age, baseline normal functional and medical status, and lack of end-organ injury, the patient was evaluated for VV-ECMO and cannulated.

Approximately one month after cannulation, in the setting of therapeutic heparinization, the patient had acute bleeding from a right pleural chest tube, which had been placed a week prior for a secondary spontaneous pneumothorax. The patient was taken to the operating room (OR) emergently for exploration through a right thoracotomy. A significant volume of hemothorax was evacuated, with significant congestion of the right lower lobe and multiple visceral pleural tears along the posterior basilar segment. The remainder of the chest was evaluated, and no other source of bleeding was identified. A J o u r n a l P r e -p r o o f wedge resection of the hemorrhagic parenchyma significantly reduced bleeding. Due to some diffuse coagulopathic bleeding while on ECMO, the chest was packed and the patient returned to the intensive care unit.

Over the subsequent hours, the patient has increasing bloody output from the chest tubes with continued pressor requirement and limited EMCO flows. The thoracotomy incision was opening in the ICU and bleeding from the right lower lobe was controlled manually to allow resuscitation. Upon return to the OR, the right lower lobe was noted to have worsening parenchymal congestion and bleeding, and the inferior pulmonary vein was dark and firm, consistent with venous thrombosis. The decision was made to perform a right lower lobectomy for definitive control of bleeding. The fissure was opened and the pulmonary artery dissected. The right lower lobe pulmonary artery branches were ligated with 2-0 silk suture and divided sharply. The inferior pulmonary vein was carefully encircled, attempting to not dislodge clot. A vascular load stapler was used to divide the vein at the level of the pericardium. The bronchus and parenchyma were subsequently divided completing the right lower lobectomy, with good hemostasis noted thereafter. The chest was irrigated and drained widely and the thoracotomy incision closed in layers. Postoperatively, he has been decannulated from ECMO and is on room air. Additionally, he has no neurologic deficits and is ambulatory with physical therapy.

Pathologic evaluation of the right lower lobe revealed hemorrhagic infarction with cavities resulting from ischemic necrosis of the lung parenchyma, and alveolar hemorrhage (Figure 1 ). The lung distant to the infarction showed focal residual hyaline membranes, interstitial inflammation consisting primarily of T cells and macrophages with extensive peribronchiolar metaplasia. Numerous megakaryocytes and platelets were present (Figure 2 ). The inferior pulmonary vein was verified as thrombosed.

Pulmonary vein thrombosis is a rare clinical entity, typically occurring in the setting of malignancy or lung transplantation [4] . Patients with severe COVID-19 are predisposed to both venous J o u r n a l P r e -p r o o f and arterial thrombosis, with pulmonary embolism emerging as the most common thrombotic complication [1, 2] . In autopsy examination of COVID-19 patients, nearly all patients had capillary congestion and platelet-fibrin thrombi in small arterial vessels (<1 mm) [5] .

To our knowledge, this is the first reported case of pulmonary lobectomy due to COVID-19.

While a parenchymal sparing strategy was initially attempted considering the patient's ongoing respiratory failure, lobectomy was eventually required for definitive hemorrhagic control in the setting of inferior venous thrombosis. Although there is no consensus regarding the management of inferior vein thrombosis, the majority of patients with complicated disease undergo pulmonary resection [4] . 

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized with COVID-19 in the New York City Area

COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review

Pulmonary Vein Thrombosis: A Recent Systematic Review

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study